NCT05292872View on ClinicalTrials.gov

Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

CompletedOBSERVATIONAL
Enrollment

4,577

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Primary Biliary Cholangitis
Trial Locations (1)

92121

Intercept Pharmaceuticals, Inc, San Diego

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Target RWE

INDUSTRY

collaborator

Syneos Health

OTHER

collaborator

Komodo Health, Inc.

INDUSTRY

lead

Intercept Pharmaceuticals

INDUSTRY